Reentry Assist (R-Assist)

Condition(s) studied

Investigational drug(s) / intervention(s)

reentry assistance mobile health app: R-Assist features will include: 1) daily self-reported symptom and medication management monitoring; 2) a 29-session MISSION-CJ self-help curriculum, with an accompanying library of recovery resources to support COD symptom management and promote prosocial thinking and behavior; 3) SDOH resource finder; and 4) a dashboard to track R-Assist engagement.

Study summary

This project will aim to develop and pilot test, R-Assist, a mobile health application to support individuals with co-occurring substance use and mental health disorders (COD) in their recovery, who have recently released from a participating Massachusetts jail.

Eligibility

Primary outcome measure(s)

• App usage — From enrollment for 1.5 months during the open pilot
  Total time engaged in app will be tracked daily during open pilot period. Additionally, engagement and time with each feature will be tracked
• System Usability Scale (SUS) — From enrollment for 1.5 months during the open pilot
  Overall score will be computed, indicating overall usability Score ranges from 0-100 (0-64=not acceptable, 65-84=acceptable, and 85, 100=excellent.
• Mobile Application Rating Scale (MARS) — From enrollment for 1.5 months during the open pilot
  Overall score will be computed, indicating overall acceptability, as well as score for each of the four dimensions. The rating scale assesses app quality on four dimensions (1. Engagement, 2. Functionality, 3. Aesthetics, and 4. Information). All items are rated on 5-point scale from "1=inadequate" to "5=excellent"
• Composite International Diagnostic Instrument for DSM-IV: Social determinants of health (SDOH) linkages — From enrollment for 1.5 months during the open pilot
  SDOH needs (e.g., housing instability, food insecurity, NA/AA/ other recovery linkages) will be assessed and the App will track all referrals and SDOH linkages made. Percent of linkages made to needed SDOH services will be examined.
• Composite International Diagnostic Instrument for DSM-IV: Substance Use Disorder — From enrollment for 1.5 months during the open pilot
  Substance use disorder symptoms will be tracked daily during the open pilot period.
• Composite International Diagnostic Instrument for DSM-IV: Mental Health — From enrollment for 1.5 months during the open pilot
  Mental health symptoms will be tracked daily during the open pilot period.

Trial sites (1)